Elypta presents interim study results
Nordic Life Science | Pharma
by
1w ago
Elypta has announced that the interim results from the LEVANTIS-0087A study will be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego during the ..read more
Visit website
Recipharm sell seven of its sites to Blue Wolf Capital Partners
Nordic Life Science | Pharma
by
1w ago
The US-based private equity firm has committed to acquire Recipharm’s sites in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain. The ..read more
Visit website
AstraZeneca to acquire Fusion Pharmaceuticals
Nordic Life Science | Pharma
by
2w ago
AstraZeneca has entered into a definitive agreement to acquire Canadian Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). Under the terms of the definitive agreement, AstraZeneca, through a ..read more
Visit website
Novo Nordisk’s Awiqli receives positive CHMP opinion
Nordic Life Science | Pharma
by
2w ago
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorization for Awiqli (the brand name for once-weekly basal insulin icodec ..read more
Visit website
Novo Nordisk to acquire Cardior Pharmaceuticals
Nordic Life Science | Pharma
by
2w ago
Novo Nordisk has agreed to acquire Cardior for up to EUR 1.025 billion, including an upfront payment and additional payments if certain development and commercial milestones are achieved. Cardior is ..read more
Visit website
Novo Nordisk’s Wegovy approved in the US for cardiovascular risk reduction
Nordic Life Science | Pharma
by
1M ago
The FDA has approved a label expansion for Wegovy based on a supplemental New Drug Application for the indication of reducing risks of major adverse cardiovascular events including cardiovascular death ..read more
Visit website
AstraZeneca to acquire Amolyt Pharma
Nordic Life Science | Pharma
by
1M ago
AstraZeneca has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. Under the terms of the agreement ..read more
Visit website
AstraZeneca to acquire Fusion
Nordic Life Science | Pharma
by
1M ago
AstraZeneca has entered into a definitive agreement to acquire Canadian Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). Under the terms of the definitive agreement, AstraZeneca, through a ..read more
Visit website
Center for Translational Research launches CTC Netherlands
Nordic Life Science | Pharma
by
1M ago
Center for Translational Research (CTR) expands its portfolio of life science service companies through the establishment of CTC Netherlands BV. CTC Netherlands BV is CTR group’s first company outside of ..read more
Visit website
Vicore enters license agreement with Nippon Shinyaku
Nordic Life Science | Pharma
by
1M ago
Vicore Pharma has entered into an exclusive licensing agreement with Nippon Shinyaku to develop and commercialize Vicore’s drug candidate C21 in Japan. Under the terms of the agreement, Vicore will ..read more
Visit website

Follow Nordic Life Science | Pharma on FeedSpot

Continue with Google
Continue with Apple
OR